Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03833921
Title Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (APRE)
Acronym APRE
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Martha Mims
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.